Michael R Jaff

DO, FACP, FACC

Dr. Michael R Jaff

Vascular Medicine Specialist

Innovator

Massachusetts General Hospital

Positions
Medical Director, Center for Specialized Services, Massachusetts General Hospital
Paul and Phyllis Fireman Endowed Chair of Vascular Medicine, Massachusetts General Hospital
Medical Director, Massachusetts General Hospital Vascular Center
Founder and Medical Director, Massachusetts General Vascular Ultrasound Core Lab
Professor of Medicine, Harvard Medical School
Chair, FDA Medical Devices Dispute Resolution Panel
Professional Interests

Dr. Jaff is an active clinical consultant in all aspects of vascular medicine, including peripheral arterial disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine. He has dedicated his career to facilitating novel clinical trial strategies for peripheral vascular device and drug evaluation, and is the founder and Medical Director of VasCore, the Vascular Ultrasound Core Laboratory, the largest of its kind in the United States. The Vascular Ultrasound Core Laboratory has participated in trial design and independent analysis of vascular laboratory images for over 160 prospective multi center international trials.

Research and Collaboration
OrganizationRolePurposeCompensation
American Orthotic & Prosthetic AssociationMemberMedical Advisory BoardConsulting Fees
Cardinal HealthConsultantImproved vascular closure devices.Consulting Fees
CBSETBoard of Directors MemberNot-for-profit basic and translational science facility assisting in the development of lifesaving therapies in cardiovascular medicine.Consulting Fees
IC SciencesInvestorPersonal investment in business.Non-compensated
Jana CareInvestorPersonal investment in business.Non-compensated
MC10InvestorPersonal investment in business.Non-compensated
MedscapeConsultantMedical EducationConsulting Fees
MicellScientific Advisory Board MemberDevelopment of novel drug-eluting stents.Equity
NorthwindInvestorPersonal investment in business.Non-compensated
NovellaDSMB MemberProvide oversight of BiO2 Medical study pursuant to BiO2's Study Protocol QD-230 Rev. BConsulting Fees
PQ BypassInvestorPersonal investment in business.Non-compensated
PrimaceaBoard of Directors ChairEthical collaborations between physicians, hospitals and the medical industry.Non-compensated
PrimaceaInvestorPersonal investment in business.Non-compensated
Sano VInvestorPersonal investment in business.Non-compensated
ValiantEquity
Vascular TherapiesInvestorPersonal investment in business.Non-compensated
VIVAPresident-Elect and Board MemberEducation for physicians and healthcare professionals dedicated to treating patients with vascular diseases.Consulting Fees
VolcanoConsultantConsulting Fees
VolcanoConsultantGeneral advice and consultingNon-compensated
Professional Highlights
Publication (06/18/2014)

Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, Kumbhani DJ, Mukherjee D, Jaff MR, Giri J. JAMA. 2014 Jun 18;311(23):2414-21. doi: 10.1001/jama.2014.5990. PMID: 24938564

Publication (04/30/2014)

Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany. Pietzsch JB, Geisler BP, Garner AM, Zeller T, Jaff MR. Catheter Cardiovasc Interv. 2014 Apr 30. doi: 10.1002/ccd.25536. [Epub ahead of print] PMID: 24782424

Publication (03/01/2014)

Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. Weinberg I, Keyes MJ, Giri J, Rogers KR, Olin JW, White CJ, Jaff MR. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):603-9. doi: 10.1002/ccd.25263. Epub 2013 Nov 9. PMID: 24307609.

Clinical Role (01/10/2014)

First recipient of an endowed chair in Vascular Medicine at Massachusetts General Hospital (Paul and Phyllis Fireman Chair in Vascular Medicine).

Biography

Michael R. Jaff, DO is Professor of Medicine at Harvard Medical School, Chair of the MGH Institute for Heart, Vascular, and Stroke Care, Medical Director of the Vascular Center, and the Medical Director of the Vascular Diagnostic Laboratory at the Massachusetts General Hospital.

Dr. Jaff is an active clinical consultant in all aspects of vascular medicine, including peripheral arterial disease, venous thromboembolic disease, aneurysmal diseases, and all diagnostic strategies in vascular medicine.

He is the founder and Medical Director of the Vascular Ultrasound Core Laboratory, the largest of its’ kind in the United States. The Vascular Ultrasound Core Laboratory has participated in trial design and independent analysis of vascular laboratory images for over 100 prospective multicenter trials.

Dr. Jaff has published extensively in the field of Vascular Medicine with over 160 peer-reviewed publications and 9 textbooks, is the Past-President of the Society for Vascular Medicine and Biology, and was the first physician to have received the designation as Master of the Society for Vascular Medicine. He is a Fellow of the American College of Physicians, American College of Cardiology, the American Heart Association, and the Society for Cardiovascular Angiography and Intervention, and is a registered physician in vascular interpretation (RPVI).

Dr. Jaff received an honorary Doctorate of Science from A.T. Still University School of Medicine in 2008, and received the “Leaders in Vascular Education” award at the annual Vascular Interventional Advances (VIVA) meeting held in Las Vegas, Nevada in October 2010. In November 2011, Dr. Jaff became an alumnus of Harvard Business School. In January 2014, Dr. Jaff was named the first incumbent of the Paul and Phyllis Fireman Endowed Chair in Vascular Medicine.